Incidence Rates for All Races, per 100,000
U.S. Population by Year, Site and Sex
SEER Incidence Rates and Trends for 1973-91a, All Ages Combined |
| Cancer Site |
Sex |
Average Rateb |
% Change |
EAPCc |
1973-74 |
1990-91 |
1973-91 |
1973-91 |
| Brain & Other Nervous |
Both Sexes |
5.0 |
6.3 |
24.6 |
1.2 d |
|
|
Male |
6.0 |
7.4 |
23.0 |
1.1 d |
|
|
Female |
4.2 |
5.3 |
27.7 |
1.3 d |
| Breast |
Both Sexes |
48.3 |
60.1 |
24.5 |
1.8 d |
|
|
Male |
1.0 |
0.9 |
- 5.7 |
0.4 |
|
|
Female |
88.6 |
109.8 |
23.9 |
1.7 d |
| Cervix Uteri |
Female |
13.5 |
8.6 |
- 36.4 |
- 2.6 d |
| Colon & Rectum |
Both Sexes |
47.1 |
47.2 |
0.3 |
0.1 |
|
|
Male |
54.7 |
57.7 |
5.4 |
0.5 d |
|
|
Female |
41.6 |
39.5 |
- 5.0 |
- 0.3 |
| Corpus & Uterus, NOS |
Female |
29.6 |
21.4 |
- 27.7 |
- 2.4 d |
| Esophagus |
Both Sexes |
3.5 |
4.0 |
14.8 |
0.7 d |
|
|
Male |
5.7 |
6.7 |
17.3 |
0.8 d |
|
|
Female |
1.8 |
1.9 |
7.2 |
0.3 |
| Hodgkin's Disease |
Both Sexes |
3.2 |
2.8 |
- 11.7 |
- 0.2 |
|
|
Male |
3.9 |
3.2 |
- 18.4 |
- 0.6 d |
|
|
Female |
2.5 |
2.4 |
- 2.7 |
0.3 |
| Kidney & Renal Pelvis |
Both Sexes |
6.5 |
8.8 |
35.4 |
2.1 d |
|
|
Male |
9.2 |
12.3 |
33.0 |
1.9 d |
|
|
Female |
4.3 |
6.0 |
39.1 |
2.3 d |
| Larynx |
Both Sexes |
4.5 |
4.4 |
- 3.0 |
- 0.1 |
|
|
Male |
8.3 |
7.7 |
- 7.2 |
- 0.5 d |
|
|
Female |
1.4 |
1.6 |
21.3 |
1.6 d |
| Leukemias |
Both Sexes |
10.7 |
9.5 |
- 11.3 |
- 0.4 d |
|
|
Male |
14.0 |
12.3 |
- 11.6 |
- 0.4 d |
|
|
Female |
8.2 |
7.3 |
- 11.2 |
- 0.5 d |
| Liver & Intrahep |
Both Sexes |
2.3 |
3.3 |
45.4 |
2.3 d |
|
|
Male |
3.2 |
5.0 |
56.2 |
2.5 d |
|
|
Female |
1.5 |
1.9 |
25.7 |
1.7 d |
| Lung & Bronchus |
Both Sexes |
43.2 |
58.1 |
34.4 |
1.7 d |
|
|
Male |
73.9 |
80.3 |
8.7 |
0.5 d |
|
|
Female |
19.1 |
41.6 |
118.0 |
4.6 d |
| Melanoma of Skin |
Both Sexes |
5.8 |
11.3 |
94.0 |
3.9 d |
|
|
Male |
6.2 |
13.4 |
117.2 |
4.7 d |
|
|
Female |
5.6 |
9.7 |
74.6 |
3.3 d |
| Multiple Myeloma |
Both Sexes |
3.8 |
4.4 |
15.9 |
0.8 d |
|
|
Male |
4.5 |
5.6 |
25.3 |
1.0 d |
|
|
Female |
3.3 |
3.4 |
5.5 |
0.6 d |
| Non-Hodgkin's Lymphoma |
Both Sexes |
8.7 |
15.1 |
72.8 |
3.3 d |
|
|
Male |
10.2 |
18.7 |
83.6 |
3.8 d |
|
|
Female |
7.5 |
11.9 |
57.4 |
2.7 d |
| Oral Cavity & Pharynx |
Both Sexes |
11.2 |
10.7 |
- 4.7 |
- 0.3 d |
|
|
Male |
17.5 |
16.2 |
- 7.4 |
- 0.6 d |
|
|
Female |
6.2 |
6.1 |
- 0.9 |
- 0.1 |
| Ovary |
Female |
14.4 |
15.0 |
4.4 |
0.4 |
| Pancreas |
Both Sexes |
9.8 |
8.8 |
- 9.8 |
- 0.4 d |
|
|
Male |
12.2 |
10.0 |
- 17.8 |
- 1.0 d |
|
|
Female |
7.9 |
7.8 |
- 1.0 |
0.3 |
| Prostate |
Male |
64.9 |
146.8 |
126.3 |
3.9 d |
| Stomach |
Both Sexes |
10.1 |
7.5 |
- 26.0 |
- 1.5 d |
|
|
Male |
14.8 |
10.9 |
- 26.3 |
- 1.4 d |
|
|
Female |
6.6 |
4.9 |
- 24.6 |
- 1.6 d |
| Testis |
Male |
3.1 |
4.5 |
42.7 |
2.2 |
| Thyroid |
Both Sexes |
3.8 |
4.6 |
21.1 |
0.9 d |
|
|
Male |
2.3 |
2.5 |
9.7 |
0.2 |
|
|
Female |
5.3 |
6.7 |
26.6 |
1.1 d |
| Urinary Bladder |
Both Sexes |
15.2 |
16.8 |
10.5 |
0.7 d |
|
|
Male |
26.4 |
29.4 |
11.4 |
0.8 d |
|
|
Female |
6.7 |
7.5 |
11.8 |
0.5 d |
| All Sites |
Both Sexes |
326.4 |
399.5 |
22.4 |
1.2 d |
|
|
Male |
368.8 |
485.1 |
31.5 |
1.5 d |
|
|
Female |
302.5 |
343.7 |
13.6 |
0.9 d |
|
a SEER program. Rates are
per 100,000 and are age-adjusted to the 1970 U.S. standard population.
b The Average Rate is the
average annual rate over the specified 2-year period.
c The EAPC is the Estimated
Annual Percent Change over the 19-year interval.
d The EAPC is significantly
different from zero (p < .05).
